Moderna gets a boost from positive vaccine trial data. Tilray shares slide on an analyst downgrade.Moderna gets a boost from positive vaccine trial data. Tilray shares slide on an analyst downgrade.
Moderna gets a boost from positive vaccine trial data. Tilray shares slide on an analyst downgrade.Moderna gets a boost from positive vaccine trial data. Tilray shares slide on an analyst downgrade.